4//SEC Filing
Ignelzi Troy A. 4
Accession 0001437749-24-017719
CIK 0001855175other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 7:00 PM ET
Size
5.3 KB
Accession
0001437749-24-017719
Insider Transaction Report
Form 4
Ignelzi Troy A.
Director
Transactions
- Award
Stock Option (right to buy)
2024-05-20+23,150→ 23,150 totalExercise: $15.71Exp: 2034-05-19→ Class A Common Stock (23,150 underlying)
Footnotes (1)
- [F1]Options granted under the Issuer's 2024 Equity Incentive Plan, pursuant to the Issuer's Non-Employee Director Compensation Plan. One-third of the option shares vest and become exercisable on May 20, 2025, and the remainder vests in 24 equal monthly installments thereafter, subject to the Reporting Person's continuous service.
Documents
Issuer
Contineum Therapeutics, Inc.
CIK 0001855175
Entity typeother
Related Parties
1- filerCIK 0001579829
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 7:00 PM ET
- Size
- 5.3 KB